These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3493696)

  • 1. Pregnancy-induced changes in the fibrinolytic balance: evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor.
    Gore M; Eldon S; Trofatter KF; Soong SJ; Pizzo SV
    Am J Obstet Gynecol; 1987 Mar; 156(3):674-80. PubMed ID: 3493696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.
    Estellés A; Gilabert J; Andrés C; España F; Aznar J
    Thromb Haemost; 1990 Oct; 64(2):281-5. PubMed ID: 2125378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.
    Pizzo SV; Fuchs HE; Doman KA; Petruska DB; Berger H
    Arch Intern Med; 1986 Jan; 146(1):188-91. PubMed ID: 2935105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fast inhibitor of tissue plasminogen activator in plasma during pregnancy.
    Wiman B; Csemiczky G; Marsk L; Robbe H
    Thromb Haemost; 1984 Oct; 52(2):124-6. PubMed ID: 6441300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
    Colucci M; Paramo JA; Collen D
    J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of delivery on plasminogen activator inhibitor activity.
    Koelbl H; Kirchheimer J; Tatra G
    J Perinat Med; 1989; 17(2):107-11. PubMed ID: 2681664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic activity and protein C in preeclampsia.
    Aznar J; Gilabert J; Estellés A; España F
    Thromb Haemost; 1986 Jun; 55(3):314-7. PubMed ID: 3092388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
    Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
    Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM; Ljungnér H; Tengborn L
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tissue plasminogen activator in sickle cell anemia.
    Phillips G; Hartman J; Keller VA; Santiago MA; Pizzo S
    Am J Hematol; 1990 Nov; 35(3):167-70. PubMed ID: 2121022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K; Nakashima Y; Sueishi K; Tanaka K
    Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED; Akkerman JW; Jansen BG
    Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
    Estellés A; Gilabert J; España F; Aznar J; Galbis M
    Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic components in fetal membranes and amniotic fluid.
    Watanabe T; Araki M; Mimuro J; Tamada T; Sakata Y
    Am J Obstet Gynecol; 1993 Apr; 168(4):1283-9. PubMed ID: 7682753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.